After three very similar surveys yielded results that pointed to disaffection and disenfranchisement on the part of the faculty at MD Anderson, the UT System officials said they expect a “renewed, constructive and collaborative effort” to address the problems.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
